Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 10:54 PM ET


Company Overview of Inovio Pharmaceuticals, Inc.

Executive Profile

Philip D. Greenberg M.D.

Member of Scientific Advisory Board, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 8 different industries.

See Board Relationships


Dr. Philip D. Greenberg, M.D. serves as Head of Program in Immunology at Fred Hutchinson Cancer Research Center. Dr. Greenberg is a Professor of Medicine in Oncology and Immunology at University of Washington. He is the scientific co-founder of Juno Therapeutics. Dr. Greenberg served as Director of the Immunology Program at FHCRC and Co-Director of the Immunology Program for UW Center for AIDS Research since 1988. He joined FHCRC and the Division of Oncology at University ...

Corporate Headquarters

660 West Germantown Pike
Plymouth Meeting, Pennsylvania 19462

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships



MD 1971
State University of New York
Unknown/Other Education
Washington University, St. Louis
Post-Doctoral Training
University of California - San Diego

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
Stanley C. Erck Chief Executive Officer, President, Director and Member of Finance Committee
Novavax, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inovio Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at